Internal Medicine · Boston, MA
NPI
1447317862
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
New England Medical Center, 750 Washington Street
Boston, MA, 02111
Phone (617) 636-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
1,876 services
Medicare patients, 2024
559
Average age 77
Drug cost, 2024
$6.3M
989 prescriptions
Company payments, 2025
$13K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James I Weitzman was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 548 times for 277 patients. In total James I Weitzman billed 1,876 services in 12 codes, and Medicare paid $156K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 548 | 277 | $13.74 | $7,532 |
| 99214 Office E&M - Established | Office | 466 | 280 | $104.62 | $49K |
| 99215 Office E&M - Established | Office | 244 | 110 | $153.96 | $38K |
| 99443 Telephone Services | Office | 161 | 122 | $103.78 | $17K |
| 99204 Office E&M - New | Office | 112 | 112 | $139.92 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 105 | 28 | $98.26 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 61 | 32 | $13.82 | $843 |
| 99215 Office E&M - Established | Facility | 59 | 24 | $114.95 | $6,782 |
| 99214 Office E&M - Established | Facility | 51 | 40 | $72.19 | $3,681 |
| 99223 Hospital E&M - Initial | Facility | 21 | 20 | $143.90 | $3,022 |
| 99443 Telephone Services | Facility | 18 | 13 | $72.21 | $1,300 |
| 99238 Hospital Discharge Management | Facility | 12 | 12 | $68.17 | $818 |
| 99205 Office E&M - New | Office | 11 | 11 | $189.18 | $2,081 |
By year: 2022 $117K for 1,091 services; 2023 $133K for 1,231 services; 2024 $156K for 1,876 services.
Medicare prescription drug claims, 2024
In 2024, the drug James I Weitzman prescribed most often to Medicare patients was Hydroxyurea, with 104 prescriptions and refills. In total James I Weitzman wrote 989 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 104 | 198 | 37 | $2,495 |
| Xarelto Rivaroxaban | 83 | 123 | 21 | $67K |
| Eliquis Apixaban | 82 | 102 | 18 | $59K |
| Acyclovir Generic | 52 | 90 | 15 | $779 |
| Jakafi Ruxolitinib Phosphate | 51 | 51 | Under 11 | $872K |
| Brukinsa Zanubrutinib | 46 | 46 | Under 11 | $626K |
| Imbruvica Ibrutinib | 41 | 41 | Under 11 | $515K |
| Prednisone Generic | 38 | 38 | 18 | $172 |
| Bosulif Bosutinib | 37 | 37 | Under 11 | $714K |
| Ninlaro Ixazomib Citrate | 37 | 38 | Under 11 | $445K |
| Ojjaara Momelotinib Dihydrochloride | 31 | 31 | Under 11 | $869K |
| Ondansetron Hcl Generic | 25 | 25 | 12 | $67.93 |
| Promacta Eltrombopag Olamine | 21 | 21 | Under 11 | $418K |
| Venclexta Venetoclax | 20 | 20 | Under 11 | $164K |
| Gabapentin Generic | 16 | 16 | Under 11 | $77.77 |
Brand drugs: 551 claims; generic drugs: 438 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James I Weitzman $13K ($13K in general payments such as food, travel and fees) from 6 companies. The largest payer was Novartis Pharmaceuticals Corporation with $5,044.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.